An Indecisive Market<br />By Rev Shark<br />RealMoney.com Contributor<br />3/1/2010 8:38 AM EST<br /><br /> Indecision and delays are the parents of failure.<br /> -- George Canning<br /><br />For three weeks now the market has been struggling to recover from a technical breakdown. The action hasn't been bad, but it has not been easy either. The bulls are holding up well but have not been able to move back over 1109, the 50-day simple moving average of the S&P 500.<br /><br />Last year the market seldom hesitated as it bounced back from a pullback. Once we started to turn back up, we'd just keep on running and cut through technical overhead as if it were meaningless.<br /><br />This time the action is much more mixed. We have had quite a few positive days and there seems to be a pretty consistent bid under the market, but we have yet to see an accumulation day -- an up day on higher volume -- since this bounce began. Volume has been quite light and leadership is a mess. Despite poor consumer confidence news, higher-than-expected weekly unemployment claims and other negative economic news, retail stocks have been leading the market. The news flow has not been very positive yet it doesn't seem to matter too much.<br /><br />The action has a bullish bias, but it's indecisive and slow. We can't be overly negative because we are holding up well and appear to have a supply of buyers providing support. On the other hand, if we don't make better progress soon there is risk that the bulls will give up or tire out. The bulls need to press their advantage while they still have it.<br /><br />In an indecisive market, we have to stay flexible and be ready to adapt should a stronger trend emerge. We have this low-energy bounce in play right now, but there is so little momentum that we can't be very trusting that it will continue. On the other hand, the bears are struggling even more and have not been able to make any progress at all.<br /><br />Today is a Monday morning and the first day of the month, both of which tend to have a positive bias. The market has done very well on Mondays for quite some time and we are off to a positive start once again.<br /><br />I'm going to be keeping time frames short and stops tights. I don't want to be bearish here, but I don't want to be very trusting of the bulls either. It's indecisive out there, and we have to keep an open eye until we see what the market wants to do. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: BID +6.2%, USU +6.2%, ROSE +2.5% (light volume), ISIS +1.0%... M&A news: OSIP +47.2% (Astellas Pharma offers to acquire OSI Pharmaceuticals for $52.00/share in cash), RISK +12.7% (MSCI to acquire RiskMetrics for $21.75/share in cash and stock), MIL +11.4% (Merck KGaA acquires Millipore for $107/share in cash)... Other news: CIIC +19.0% (still checking), ARIA +13.8% (receives Orphan Drug Designations for its investigational pan BCR-ABL inhibitor, AP24534, in chronic myeloid leukemia), AIG +8.6% (AIG to sell AIA to Prudential for approx $35.5 bln; upgraded to Buy at Societe Generale), BIOD +5.3% (announces FDA Accepts VIAject NDA for Review), PLL +5.1% (up in sympathy with MIL), ELN +5.0% (announces that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits), VVUS +3.6% (announces FDA acceptance of Qnexa new drug application for treatment of obesity), NUVA +2.5% (announces additional insurance provider XLIF policy reversal; upgraded to Strong Buy at Needham, target raised to $53 at JP Morgan following XLIF removal from experimental procedures), MRH +1.5% (purchases 6.9 mln of its common shares in a private transaction), SPWRA +1.4% (signs 32-megawatt solar power supply agreement with Toshiba), FCX +1.1% (Chile quake impact on copper's limited, Goldman says - DJ), ... Analyst comments: ASIA +4.5% (upgraded to Buy from Neutral at Goldman), ESV +3.2% (added to Conviction Buy List at Goldman), DNR +3.0% (upgraded to Buy at KeyBanc Capital Mkts), CVH +2.7% (upgraded to Overweight from Equal Weight at Morgan Stanley), PALM +1.5% (Buy PALM in the aftermath - MKM Partners), BRY +1.3% (upgraded to Outperform from Market Perform at Raymond James ),<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: PUK -13.5%, GAME -12.0%, HBC -7.6%, SNDA -6.5%, CEDC -4.8%, PWRD -3.5%, IPI -2.6%... M&A news: MXB -8.3% (MSCI to acquire RiskMetrics for $21.75/share in cash and stock)... Select financial related names showing weakness: LYG -7.7%, AIB -6.4%, IRE -6.1%, BCS -5.6%, CS 1.4%... Select metals/mining names trading lower: GOLD -2.0%, RTP -1.4% (Rio Tinto increases ownership in Ivanhoe Mines to 22.4% with $232 mln purchase of shares), AU -0.8%, ... Other news: AV -7.4% (still checking), SOLR -5.0% (filed for a 25 mln share common stock offering by selling shareholders), OSK -2.3% (mentioned negatively in Barron's), BT -1.3% (still checking), DMND -1.0% (announces it has commenced an offering of 4,500,000 shares of common stock)... Analyst comments: TASR -5.4% (downgraded to Neutral at JP Morgan), SIRI -3.9% (downgraded to Hold at Wunderlich), ITRN -1.0% (downgraded to Underweight from Neutral at JP Morgan), ANF -0.7% (downgraded to Sell from Hold at Brean Murray).